Mirum Pharmaceuticals, Inc. - COM (MIRM)

Historical Portfolio Holders from Q3 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
53.1M
Holdings value Q2 2024
$1.82B
Value change Q2 2024
+$11.9M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
156
Number of buys Q2 2024
27
Number of sells Q2 2024
-14
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 3.46M $135M -$21.4M $39.00 46
2024 Q2 53.1M $1.82B +$11.9M $34.19 159
2024 Q1 53.2M $1.34B +$75.9M $25.12 168
2023 Q4 49.7M $1.47B -$8.75M $29.52 185
2023 Q3 48.7M $1.54B +$392M $31.60 157
2023 Q2 36.9M $956M +$63.1M $25.87 144
2023 Q1 34.7M $833M +$34M $24.02 114
2022 Q4 33.3M $650M -$12.4M $19.50 101
2022 Q3 33.7M $709M +$93.2M $21.01 106
2022 Q2 29.3M $568M +$47.5M $19.46 103
2022 Q1 26.8M $590M -$6.24M $22.02 98
2021 Q4 22.9M $365M +$18.8M $15.95 80
2021 Q3 21.4M $427M +$2.08M $19.92 69
2021 Q2 21.5M $371M +$643K $17.29 66
2021 Q1 21.5M $425M -$8.43M $19.82 60
2020 Q4 22M $384M +$52.3M $17.46 71
2020 Q3 18.7M $361M -$1.29M $19.27 50
2020 Q2 18.8M $366M +$8.94M $19.46 57
2020 Q1 18.6M $260M +$32.1M $14.00 43
2019 Q4 16.2M $398M +$12.8M $24.52 39
2019 Q3 16.5M $166M +$166M $10.06 38